Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Dosing - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar
Pharmaceutics | Free Full-Text | Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect
Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events | AAFP
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar
Dosing of direct oral anticoagulants in atrial fibrillation based on... | Download Table
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article
What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho,
Life on a Blood Thinner: Insights and Advice from an Anticoagulant Specialist - YouTube
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect
Rivaroxaban: a fully-subsidised oral anticoagulant
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar
Xarelto® - Dosing Guide
Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve | NEJM
Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv
Safety Profile - NVAF | XARELTO® (rivaroxaban) HCP
Anticoagulation therapy in Atrial Fibrillation patients at high bleeding risk
Doses Studied in RCTs of Rivaroxaban and Dabigatran - Prevention and Treatment of Venous Thromboembolism - Advances in Anticoagulation for Venous Thromboembolism
Direct Oral Anticoagulants - ppt video online download
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study - Staerk - 2018 - Journal of Internal Medicine - Wiley Online Library
Xarelto® – Dosing – Stroke Prevention in Atrial Fibrillation
Dose Regimens in Approved Rivaroxaban Indications. 1 | Download Table
